AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced the signing of $2.1 million of clinical consulting contracts with several leading pharmaceutical companies.
These contracts cover a wide range of therapeutic areas including oncology, neurology, gastroenterology, cardiovascular diseases, vaccines, and infectious diseases. These agreements reflect Covalent's ongoing strategy of leveraging its consultative services to drive comprehensive research management and development programs.
By partnering early in the development process with pharmaceutical companies, Covalent is able to proactively optimize the design and conduct of clinical trials. Covalent's consultative approach to clinical development benefits its clients by focusing on innovative results-oriented solutions and integrating these solutions with operational expertise and experience.
Kenneth M. Borow, MD, ...
Source: HighBeam Research, $2.1M clinical consulting contracts announced.